Urimax F Capsule (10 Cap)

About Urimax F Capsule:

Urimax F Capsule is a combination medicine, indicated to treat signs and symptoms of the enlarged prostate gland in men.

Each hard gelatin Urimax F capsule contains Tamsulosin Hydrochloride 0.4 mg (As modified-release pellets), and Finasteride 5 mg (As film-coated tablet).

Tamsulosin belongs to a class of alpha-blockers. By relaxing the smooth muscles in the prostate and bladder neck, it improves urine flow, thereby, suppressing the symptoms of benign prostatic hyperplasia.

Finasteride belongs to a class of antiandrogen medicines. It acts by decreasing the production of a certain natural hormone (dihydrotestosterone) in the body, responsible for the development and enlargement of the prostate gland.

Use of Urimax F Capsule:

Urimax F Capsule is prescribed for the treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate.

Usage Direction of Urimax F Capsule:

• Urimax F Capsule is intended for oral use only, in a dose and direction as prescribed by the physician.
• Urimax F Capsule is taken whole with the help of water.
• Do not crush, chew or break the capsule.
• Do not skip or stop the medicine without the physician’s advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Urimax F Capsule:

• If hypersensitive or allergic to Urimax F Capsule, inform the physician immediately.
• Patients should be told about the possible occurrence of symptoms related to postural hypotension such as dizziness and syncope when taking tamsulosin hydrochloride, and they should be cautioned about driving, operating machinery, or performing hazardous tasks.
• Patients should be advised about the possibility of priapism as a result of treatment with tamsulosin hydrochloride and other similar medications. Patients should be informed that this reaction is extremely rare, but if not brought to immediate medical attention, can lead to permanent erectile dysfunction (impotence).
• Prostate cancer and BPH (benign prostatic hyperplasia) frequently co-exist; therefore, patients should be screened for the presence of prostate cancer before treatment with Urimax F Capsule and at regular intervals afterward.
• Patients considering cataract surgery should be advised to tell their ophthalmologist that they have taken Urimax F Capsule.
• Physicians should inform patients that the volume of ejaculation may be decreased in some patients during treatment with  Urimax F Capsule.
• If found any other complications, inform the physician immediately.
• The Physician should be well informed when concomitant consumption of this capsule with any other medicines or supplements.
• Exposure of women-Risk to male foetus: Finasteride present in this capsule is absorbed through the skin. Therefore, women who are pregnant or may be pregnant should not handle crushed or broken capsules of Urimax F because of the possibility of absorption of the medicine and the potential risk of a foetal anomaly to a male foetus.
• Urimax F Capsule is not indicated for use in pediatric patients or women.
• Keep out of reach of children.

Storage condition of Urimax F Capsule:

Store in a cool, dry place.